Find disease awareness content and relevant supporting materials
Disseminated intravascular coagulation.
Disseminated intravascular coagulation (DIC) is a reflection of an underlying systemic disorder which affects the coagulation system, simultaneously resulting in pro-coagulant activation, fibrinolytic activation, and consumption coagulopathy....
Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).
Purpose: The Italian Society for Thrombosis and Haemostasis commissioned a project to develop clinical practice guidelines for the diagnosis and treatment of DIC.
Thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
The objective of this guideline is to provide healthcare professionals with clear, up-to-date, and practical guidance on the management of TTP and related thrombotic microangiopathies, defined by thrombocytopenia, microangiopathic haemolytic...
Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO
Acquired coagulation inhibitors result from immune-mediated depletion or inhibition of a coagulation factor. Inhibitors are most commonly directed against factor VIII (FVIII) and von Willebrand factor (VWF) and inhibitors against...
Revised Guidelines for the Diagnosis and Management of Hairy Cell Leukaemia and Hairy cell Leukaemia Variant
The British Committee for Standards in Haematology first produced guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant in 2000.
The efficacy and safety of cryoprecipitate in the treatment of acquired hypofibrinogenaemia.
Acquired hypofibrinogenaemia can result in haemorrhage and significant morbidity and mortality. Cryoprecipitate is well established as the treatment of acquired hypofibrinogenaemia in the UK.